Skip to main content
. 2020 May 8;148:e102. doi: 10.1017/S095026882000093X

Table 2.

The frequency of HIV-1 drug resistance mutations among the participants

Drug resistance mutations Total (%) HIV-1 Strain types
CRF08_BC (%) Others (%)
NRTIs
M41L 2 (0.6) 2 (0.6) 0
A62V 1 (0.3) 1 (0.3) 0
K65KR 5 (1.5) 4 (1.2%) 1 (0.3)
D67DN 2 (0.6) 2 (0.6) 0
T69D 1 (0.3) 1 (0.3) 0
V75VI 1 (0.3) 0 1 (0.3)
T215D 1 (0.3) 1 (0.3) 0
NNRTIs
K101E 3 (0.9) 2 (0.6) 1 (0.3)
K103N/KN/KQR 3 (0.9) 3 (0.9) 0
V106I/VI 9 (2.8) 5 (1.6) 4 (1.2%)
E138A/EA/G/EG/K/R 46 (14.3) 45 (14.0) 1 (0.3)
V179E/T/D/DE/VD/VDE 44 (13.7) 28 (8.7) 16 (5.0)
Y188L/N/YC/YF 4 (1.2) 4 (1.2%) 0
G190A 1 (0.3) 1 (0.3) 0
H221Y/HY 3 (0.9) 1 (0.3) 2 (0.6)
P225H 3 (0.9) 3 (0.9) 0
PIs
D30DN 1 (0.3) 1 (0.3) 0
I47IV 1 (0.3) 1 (0.3) 0
I50IV 1 (0.3) 0 1 (0.3)
V82VL 1 (0.3) 1 (0.3) 0
PR Accessory
K20T 1 (0.3) 1 (0.3) 0
L24LF 1 (0.3) 1 (0.3) 0
V32LV 1 (0.3) 0 1 (0.3)
L33F 1 (0.3) 0 1 (0.3)
I47IK 1 (0.3) 0 1 (0.3)
G48GE 1 (0.3) 1 (0.3) 0
I50IT 1 (0.3) 1 (0.3) 0
Q58QE 1 (0.3) 1 (0.3) 0
I84IK 1 (0.3) 1 (0.3) 0
 L89MV 1 (0.3) 0 1 (0.3)